# TCAF1

## Overview
TCAF1, or TRPM8 channel-associated factor 1, is a gene that encodes a protein involved in the regulation of transient receptor potential (TRP) channels, particularly TRPM8. The protein encoded by TCAF1 is a regulatory factor that modulates the activity of TRP channels, which are integral to various cellular processes, including calcium signaling and cellular response to stress. TCAF1 plays a pivotal role in maintaining genomic stability by facilitating TRPV2-mediated calcium release, which is crucial for protecting replication forks during cellular stress. This function underscores its importance in preventing genomic instability and its potential implications in cancer biology, particularly in prostate cancer, where its expression levels and promoter methylation status have been linked to disease progression and prognosis (Gkika2015TRP; Kong2024TCAF1).

## Function
TCAF1 (TRPM8 channel-associated factor 1) plays a crucial role in maintaining genome integrity and cellular survival under replication stress conditions. It is involved in the TRPV2-mediated calcium (Ca2+) release pathway, which is essential for protecting replication forks and ensuring chromosomal stability. TCAF1 facilitates the dissociation of STING from TRPV2, relieving TRPV2 repression and promoting Ca2+ release from the endoplasmic reticulum. This Ca2+ release activates the CaMKK2/AMPK pathway, leading to the phosphorylation of Exo1, which prevents aberrant processing of replication forks (Kong2024TCAF1).

In healthy human cells, TCAF1's function in promoting TRPV2-dependent Ca2+ elevation is critical for maintaining genome stability and preventing diseases such as cancer. TCAF1 interacts with multiple TRP channels, including TRPM8, TRPV6, and TRPM2, suggesting a broader role in modulating TRP channel activity (Kong2024TCAF1). TCAF1 is also involved in the cellular response to cytosolic DNA by modulating Ca2+ signaling pathways, which are important for protecting stressed replication forks (Kong2024TCAF1). This function highlights TCAF1's role in cell biology as a genome protection factor, ensuring cell survival during replication stress (Kong2024TCAF1).

## Clinical Significance
TCAF1 (TRPM8 channel associated factor 1) has significant clinical implications, particularly in prostate cancer. Alterations in TCAF1 expression and its interactions with TRPM8 are linked to prostate cancer progression. TCAF1 is highly expressed in prostate cancer tissues, but its expression decreases in metastatic tissues, suggesting its potential as a prognostic marker alongside TRPM8 and PSA (Gkika2015TRP). TCAF1 also plays a role in reducing cell migration in prostate cancer, acting as a TRPM8 activator, which may influence cancer progression and metastasis (Gkika2015TRP).

TCAF1 promoter hypermethylation is frequently observed in prostate cancer, contributing to gene downregulation. This hypermethylation is associated with adverse prognostic factors and biochemical recurrence (BCR) after radical prostatectomy, making it an independent predictor of BCR (Strand2016RHCG). The hypermethylation of TCAF1, when analyzed as a dichotomized variable, enhances the prognostic assessment of prostate cancer beyond traditional clinical parameters (Strand2016RHCG).

In addition to its role in prostate cancer, TCAF1 is involved in genome protection by facilitating TRPV2-mediated Ca2+ release, which is crucial for cell survival under replication stress. This function suggests that TCAF1 may suppress cancer initiation by preventing genomic instability, although it might also promote cancer progression by protecting the genome in cancer cells (Kong2024TCAF1).

## Interactions
TCAF1 (TRPM8 channel associated factor 1) is known to interact with several proteins, playing a significant role in cellular signaling pathways. TCAF1 associates with the TRPV2 ion channel, facilitating TRPV2-mediated calcium release in response to cytosolic DNA. This interaction is crucial for protecting replication forks under stress conditions by promoting the dissociation of STING from TRPV2, thereby relieving TRPV2 repression and enabling calcium release (Kong2024TCAF1).

The interaction between TCAF1 and STING is partially mediated by TRPV2. Co-immunoprecipitation experiments have shown that TCAF1 associates with both STING and TRPV2 in cells. Depletion of TRPV2 reduces the TCAF1-STING association, while STING knockdown does not affect the TCAF1-TRPV2 association. A mutant form of STING that is deficient in TRPV2 interaction shows reduced association with TCAF1 compared to the wild-type STING (Kong2024TCAF1).

TCAF1 also interacts with other TRP channels, including TRPM8, TRPV6, and TRPM2, suggesting a broader role in regulating TRP channel activity. In the context of TRPM8, TCAF1 facilitates the opening and migration of the channel, while TCAF2 has an antagonistic effect, suppressing TRPM8 activity (Hsieh2020Opposing).


## References


[1. (Gkika2015TRP) Dimitra Gkika, Loic Lemonnier, George Shapovalov, Dmitri Gordienko, Céline Poux, Michela Bernardini, Alexandre Bokhobza, Gabriel Bidaux, Cindy Degerny, Kathye Verreman, Basma Guarmit, Mohamed Benahmed, Yvan de Launoit, Rene J.M. Bindels, Alessandra Fiorio Pla, and Natalia Prevarskaya. Trp channel–associated factors are a novel protein family that regulates trpm8 trafficking and activity. Journal of Cell Biology, 208(1):89–107, January 2015. URL: http://dx.doi.org/10.1083/jcb.201402076, doi:10.1083/jcb.201402076. This article has 84 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201402076)

2. (Hsieh2020Opposing) Opposing selective forces operating on human-specific duplicated TCAF genes in Neanderthals and humans. This article has 2 citations.

[3. (Kong2024TCAF1) Lingzhen Kong, Chen Cheng, Abigael Cheruiyot, Jiayi Yuan, Yichan Yang, Sydney Hwang, Daniel Foust, Ning Tsao, Emily Wilkerson, Nima Mosammaparast, Michael B. Major, David W. Piston, Shan Li, and Zhongsheng You. Tcaf1 promotes trpv2-mediated ca2+ release in response to cytosolic dna to protect stressed replication forks. Nature Communications, May 2024. URL: http://dx.doi.org/10.1038/s41467-024-48988-6, doi:10.1038/s41467-024-48988-6. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-48988-6)

[4. (Strand2016RHCG) Siri H. Strand, Michal Switnicki, Mia Moller, Christa Haldrup, Tine M. Storebjerg, Jakob Hedegaard, Iver Nordentoft, Soren Hoyer, Michael Borre, Jakob S. Pedersen, Peter J. Wild, Jong Y. Park, Torben F. Orntoft, and Karina D. Sorensen. Rhcg and tcaf1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Oncotarget, 8(4):5774–5788, December 2016. URL: http://dx.doi.org/10.18632/oncotarget.14391, doi:10.18632/oncotarget.14391. This article has 22 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.14391)